JP2016536347A5 - - Google Patents

Download PDF

Info

Publication number
JP2016536347A5
JP2016536347A5 JP2016544354A JP2016544354A JP2016536347A5 JP 2016536347 A5 JP2016536347 A5 JP 2016536347A5 JP 2016544354 A JP2016544354 A JP 2016544354A JP 2016544354 A JP2016544354 A JP 2016544354A JP 2016536347 A5 JP2016536347 A5 JP 2016536347A5
Authority
JP
Japan
Prior art keywords
gly
peptide
cirp
pharmaceutical composition
disease
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016544354A
Other languages
English (en)
Japanese (ja)
Other versions
JP6615100B2 (ja
JP2016536347A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/057141 external-priority patent/WO2015048083A1/en
Publication of JP2016536347A publication Critical patent/JP2016536347A/ja
Publication of JP2016536347A5 publication Critical patent/JP2016536347A5/ja
Application granted granted Critical
Publication of JP6615100B2 publication Critical patent/JP6615100B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016544354A 2013-09-24 2014-09-24 低温誘導性rna結合タンパク質活性を阻害するペプチド Expired - Fee Related JP6615100B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361881798P 2013-09-24 2013-09-24
US61/881,798 2013-09-24
PCT/US2014/057141 WO2015048083A1 (en) 2013-09-24 2014-09-24 Peptides inhibiting cold-inducible rna binding protein activity

Publications (3)

Publication Number Publication Date
JP2016536347A JP2016536347A (ja) 2016-11-24
JP2016536347A5 true JP2016536347A5 (enExample) 2017-11-02
JP6615100B2 JP6615100B2 (ja) 2019-12-04

Family

ID=51842763

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016544354A Expired - Fee Related JP6615100B2 (ja) 2013-09-24 2014-09-24 低温誘導性rna結合タンパク質活性を阻害するペプチド

Country Status (7)

Country Link
US (1) US9957295B2 (enExample)
EP (1) EP3049438B1 (enExample)
JP (1) JP6615100B2 (enExample)
CN (2) CN105764923A (enExample)
AU (1) AU2014326974B2 (enExample)
CA (1) CA2925087C (enExample)
WO (1) WO2015048083A1 (enExample)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9957295B2 (en) 2013-09-24 2018-05-01 The Feinstein Institute For Medical Research Peptides inhibiting cold-inducible RNA binding protein activity
US20180110746A1 (en) * 2015-04-06 2018-04-26 University Of Maryland, Baltimore Small molecule inhibitors of tlr2 signaling
KR101745520B1 (ko) 2015-05-29 2017-06-12 아주대학교산학협력단 신규한 tlr4 길항제
CN108864311A (zh) * 2018-08-03 2018-11-23 中国人民解放军第四军医大学 一种抑制md2与cirp蛋白结合的短肽及其应用
US11001608B2 (en) 2019-07-11 2021-05-11 King Faisal University Arid5a peptide inhibitors
CN113616776A (zh) * 2021-08-20 2021-11-09 兰州大学第二医院 一种阻断剂c23在制备治疗心肌梗死的药物中的应用
CN114705848B (zh) * 2022-04-07 2022-10-25 中国中医科学院中药研究所 Ctrp3与ctrp15作为生物标志物在制备早期诊断自发性脑出血产品中的应用

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172124A (en) 1978-04-28 1979-10-23 The Wistar Institute Method of producing tumor antibodies
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
US5225539A (en) 1986-03-27 1993-07-06 Medical Research Council Recombinant altered antibodies and methods of making altered antibodies
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US4946778A (en) 1987-09-21 1990-08-07 Genex Corporation Single polypeptide chain binding molecules
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
IL162181A (en) 1988-12-28 2006-04-10 Pdl Biopharma Inc A method of producing humanized immunoglubulin, and polynucleotides encoding the same
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
DE69233482T2 (de) 1991-05-17 2006-01-12 Merck & Co., Inc. Verfahren zur Verminderung der Immunogenität der variablen Antikörperdomänen
AU665025B2 (en) 1991-09-23 1995-12-14 Cambridge Antibody Technology Limited Production of chimeric antibodies - a combinatorial approach
CA2115811A1 (en) 1993-02-17 1994-08-18 Claus Krebber A method for in vivo selection of ligand-binding proteins
US5919661A (en) 1997-08-25 1999-07-06 Incyte Pharmaceuticals, Inc. Polynucleotides encoding cytokine inducible regulatory protein
JPH11199507A (ja) 1998-01-09 1999-07-27 Chugai Pharmaceut Co Ltd 脳疾患及び神経疾患治療薬
WO2001009387A1 (en) 1999-07-29 2001-02-08 Northeastern University Isolation of novel hemapoietic genes by representational difference analysis
US6610713B2 (en) 2000-05-23 2003-08-26 North Shore - Long Island Jewish Research Institute Inhibition of inflammatory cytokine production by cholinergic agonists and vagus nerve stimulation
US7317077B2 (en) 2001-11-16 2008-01-08 Nymox Pharmaceutical Corporation Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells
CN1980649A (zh) 2004-05-17 2007-06-13 康宾纳特克斯公司 治疗免疫炎性疾病的方法和试药
CA2675954A1 (en) * 2007-01-18 2008-07-24 Plant Bioscience Limited (Pbl) Methods and compositions for modulating the mirna pathway
WO2009090287A1 (es) * 2008-01-17 2009-07-23 Fundació Institut de Recerca de L'Hospital Universitari Vall d'Hebron Compuestos antitumorales basados en cirp
JP2012503673A (ja) * 2008-09-25 2012-02-09 ティッシュ リジェネレーション システムズ インコーポレイテッド ミネラルコーティングされたマイクロスフェア
CA2758449C (en) * 2009-04-13 2021-11-30 The Feinstein Institute For Medical Research Treatment of inflammatory diseases by inhibiting cold-inducible rna-binding protein (cirp)
US20140193412A1 (en) 2013-01-10 2014-07-10 The Feinstein Institute For Medical Research Treatment of cutaneous wounds by inhibiting cold shock proteins
US9957295B2 (en) 2013-09-24 2018-05-01 The Feinstein Institute For Medical Research Peptides inhibiting cold-inducible RNA binding protein activity

Similar Documents

Publication Publication Date Title
JP2016536347A5 (enExample)
JP2020022459A5 (enExample)
JP2013510391A5 (enExample)
JP2009215294A5 (enExample)
JP2013539454A5 (enExample)
PH12018501912A1 (en) Vaccine against rsv
JP2011087580A5 (enExample)
JP2012530749A5 (enExample)
GB201206559D0 (en) Polypeptide
JP2009144170A5 (enExample)
JP2016525888A5 (enExample)
JP2009515982A5 (enExample)
WO2010111436A3 (en) Antiviral compounds and uses thereof
RU2018137842A (ru) Агонисты рецепторов глюкагона/glp-1 для лечения ожирения
JP2013518118A5 (enExample)
JP2010535026A5 (enExample)
JP2015532645A5 (enExample)
WO2011158044A3 (en) Respiratory formulations containing p38 mapk inhibitors
JP2012529447A5 (enExample)
JP2013503110A5 (enExample)
JP2012001634A5 (enExample)
MY160722A (en) Preparing high order hydridosilane compounds
JP2013517350A5 (enExample)
WO2013012563A3 (en) Low gwp heat transfer compositions containing difluoromethane and 1,3,3,3-tetrafluoropropene
JP2012523460A5 (enExample)